Facet Fusion Research Studies and ArticlesArticles See Below--minSurg
--VerteLoc
--VGinnovations, Inc
for the Treatment of Long Bone Fractures and for the Use In Sprinal Fusion Procedures.
ODC's TruFUSE Procedure Tops 1,750 Patients in First YearOrthopedic Development Corporation's TruFUSE Procedure Tops 1,750 Patients in First Year
minSURG Corporation announces that more than 1,750 patients have received the TruFUSE® posterior fusion procedure since its introduction last year.
Clearwater, FL (PRWEB) September 25, 2007 -- minSURG Corporation announced today that over 1,750 patients have received the TruFUSE® posterior fusion procedure since its introduction last year. TruFUSE, one of the first intermediate surgical solutions to treat intractable back pain, has been in limited distribution. The TruFUSE technique uses two small cork-shaped dowels made of human bone, called allografts, to stabilize vertebrae, and is used mostly in the lower, or lumbar, spine. The dowels are inserted using an entirely percutaneous or minimally invasive, minimally destructive technique between facet joints in the back to stop movement and pain. The TruFUSE technique is one of the first intermediate surgical options to fill the large void between traditional non-surgical back pain management and major spine fusion surgery. Two dowels are used to fuse one vertebra. TruFUSE has been used on select patients since March 2006, and went into limited distribution in August 2006. With 30 distributors and over 100 hospital approvals and active surgeons, minSURG is preparing a broad market launch and expects to train and certify an additional 400 to 500 surgeons before the end of the year.
James Doulgeris, MinSURG’s president and CEO, said, “TruFUSE represents a new, intermediate surgical option for many chronic back pain sufferers where there was none before. We are strongly encouraged by its rapidly broadening acceptance, particularly by patients, as an endorsement that validates TruFUSE’s potential. With experienced management and systems in place to serve a much larger segment of the medical and healthcare community, both here and abroad, we are looking forward to the challenge of growing TruFUSE into a major surgical solution in the coming months.”
TruFUSE is used to treat a variety of back problems, including augmentation of other procedures, for any location from C2-C3 to L5-S1. Compared to many existing methods, TruFUSE is generally less invasive, less destructive, less complicated, less expensive and subjects the patients to relatively minimal risk. It is also one of the few surgical options that can supplement or stand alone without precluding other options.
VG Innovations, LLC Announces the Introduction of the VerteLoc™VG Innovations, LLC Announces the Introduction of the VerteLoc™ Minimally Invasive Spine Stabilization System
VG Innovations, LLC (VGI), announces revolutionary new minimally invasive spine stabilization system called VerteLoc™. First surgical procedure was successfully performed on May 27, 2008. Winston-Salem, NC (PRWEB) July 17, 2008 -- VG Innovations, LLC (VGI), announced today that it has launched its' revolutionary new minimally invasive spine stabilization system called VerteLoc™.
VerteLoc™ is designed to address minor spinal instabilities by effectively stabilizing the spinal facets, which are multi-directional joints of the spinal column.
"Our goal was to design a complete system that was minimally invasive and effective in stabilization," stated VGI's President and CEO, Dan Grayson. "We believe the procedure could make a significant difference in the way surgeons address minor spinal instabilities caused by various indications. Our unique patent pending allograft implant design, which combines two unique geometric shapes, and innovative directional instrumentation have been designed to allow our surgeon users to replicate the VerteLoc™ procedure regarding a variety surgical approaches," Grayson added.
The first surgery, using the VerteLoc™ system, was successfully performed on May 27, 2008. VGI already has an established distributor network in major metropolitan areas of the United States and expects to build upon that network rapidly. The VerteLoc™ Minimally Invasive Spine Stabilization System is designed to allow earlier intervention in the continuum of spinal care. The procedure should prolong or prevent more invasive spine procedures in indicated patients, which would provide significant benefits to the quality of life versus traditional methods of spinal fusion.
VerteLoc™ Minimally Invasive Spine Stabilization SystemVerteLoc™ Minimally Invasive Spine Stabilization System Now Implanted in Over 100 Patients in the United States
VG Innovations, Inc. (VGI), announced today that over 100 patients have received implantation of the VerteLoc™ Minimally Invasive Spine Stabilization System. Early results indicate successful spinal fusion with no implant migration. Winston-Salem, NC (PRWEB) December 3, 2008 -- VG Innovations, Inc. (VGI), announced today that over 100 patients have received implantation of the VerteLoc™ Minimally Invasive Spine Stabilization System.
"This is one of many milestones our company has achieved since the launch of VerteLoc™ in late May," stated VGI's President and CEO, Dan Grayson. "We have received very positive feedback from our surgeon users, who have conveyed that our dual geometric-shaped implant provides a clear advantage when dealing with the biomechanical characteristics of the spinal column. Our review of several computed tomography images from random patients, at 12 weeks post-operative, has exhibited successful spinal facet fusion with no implant migration."
VGI was just recognized by Millennium Research Group in its report, US Markets for Minimally Invasive Spine Technologies 2008, as being the top emerging company in the facet fixation market space, which the report estimates to be worth $385 million by 2012. The report stated, "This company (VGI) will be able to leverage off of efforts made by its predecessors in promoting facet fixation technology using an allograft. Furthermore, its patent pending rectangular design, with dual vertical stabilizers, is expected to minimize the risk of dowel displacement following implantation, a major concern with competing allograft dowels."
"To be recognized by the leading source in medical device market analysis at such an early stage is quite an accomplishment," Grayson added. "However, I think the report and what it stated regarding VGI and the VerteLoc™ system is right on target. The system offers a significant advancement in design to improve the quality of life for those who suffer with debilitating back pain."
The VerteLoc™ Minimally Invasive Spine Stabilization System is designed to allow earlier intervention in the continuum of spinal care. The procedure should prolong or prevent more invasive spine procedures in indicated patients, which would provide significant benefits to the quality of life versus traditional methods of spinal fusion. VG Innovations, LLC Announces The Appointment of Moni Stein, M.DVG Innovations, LLC Announces The Appointment of Moni Stein, M.D to its Scientific Advisory Board
VG Innovations, LLC (VGI), announces that the pioneer of percutaneous spinal facet fusion procedures has been appointed to its Scientific Advisory Board. Dr. Moni Stein's research won the Young Investigator Award in 1993.
Winston-Salem, NC (PRWEB) September 22, 2008 -- VG Innovations, LLC (VGI), announced today that the pioneer of a unique percutaneous spinal facet fusion procedure has been appointed to its Scientific Advisory Board.
Moni Stein, M.D., pioneered a unique surgical approach to spinal facet fusion in 1993. His innovative research, entitled, Percutaneous Facet Fusion: Preliminary Experience, won the prestigious Society of Interventional Radiology's Young Investigator Award.
"Facet joints are an important contributor to the complex entity of degenerative spine disease and deserves special attention with specific treatment options," stated Dr. Stein. "The concept of facet fusion was initiated approximately 15 years ago and VGI has taken the concept to a new level with direct application to humans suffering of facet related back pain. This represents a new treatment path which is designed to address facet-related back pain. This modality may be applied surgically in conjunction with other back surgery or as an independent procedure done percutaneously", continued Dr. Stein. "It is very exciting to join an innovative company that addresses an important medical entity in a unique, minimally invasive way." "His comprehension of the facet joints, as a pain generator, will be helpful in assisting other surgeons to understand the importance of earlier intervention in the continuum of spinal care," stated VGI President and CEO, Dan Grayson. "Several companies have noted Dr. Stein's prior art in their patent applications, but Dr. Stein chose VGI because we have successfully elevated his original concept to an entirely new level. I think the spine community will be quite amazed with the technology that is forthcoming from VGI."
Dr. Stein is already in the planning stages to utilize the early successful outcome results of the VerteLoc procedure as a follow-up to his research and prior art. An article written by Dr. Stein (http://www.verteloc.com/pdf/opn_sept08_article.pdf), entitled Facet Fusion - The Shape of Things to Come, appears in the September / October edition of Orthopedic Product News. The VerteLoc™ Minimally Invasive Spine Stabilization System is designed to allow earlier intervention in the continuum of spinal care. The procedure should prolong or prevent more invasive spine procedures in indicated patients, which would provide significant benefits to the quality of life versus traditional methods of spinal fusion.
Back to Return to Facet Fusion Return to Facet Fusion Dockets Please enter the Password. |